Benefits of an integrated approach to viral vector manufacturing
Benefits of an integrated approach to viral vector manufacturing
バイオ製薬企業が社内での開発・製造ではなく、ウイルスベクターの開発・製造に豊富な経験を持つ総合的なCROやCDMOと提携を選ぶ理由をご覧ください。

Added Date:

2024-01-22

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • January
Capability
  • Viral Vectors
Year
  • 2024
Language
  • Japanese
Asset Type
  • Blog
Country
  • Japan
Region
  • Asia Pacific (APAC)
Market Category
  • Advanced therapy

Country Availability:


()

Gated Form:

None Set